| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:07:55 -0700 |
| HMDB ID |
HMDB00123 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Glycine |
| Description |
Glycine is a simple, nonessential amino acid, although experimental animals show reduced growth on low-glycine diets. The average adult ingests 3 to 5 grams of glycine daily. Glycine is involved in the body's production of DNA, phospholipids and collagen, and in release of energy. Glycine levels are effectively measured in plasma in both normal patients and those with inborn errors of glycine metabolism. (http://www.dcnutrition.com/AminoAcids/) Nonketotic hyperglycinaemia (OMIM 606899 ) is an autosomal recessive condition caused by deficient enzyme activity of the glycine cleavage enzyme system (EC 2.1.1.10). The glycine cleavage enzyme system comprises four proteins: P-, T-, H- and L-proteins (EC 1.4.4.2, EC 2.1.2.10 and EC 1.8.1.4 for P-, T- and L-proteins). Mutations have been described in the GLDC (OMIM 238300 ), AMT (OMIM 238310 ), and GCSH (OMIM 238330 ) genes encoding the P-, T-, and H-proteins respectively. The glycine cleavage system catalyses the oxidative conversion of glycine into carbon dioxide and ammonia, with the remaining one-carbon unit transferred to folate as methylenetetrahydrofolate. It is the main catabolic pathway for glycine and it also contributes to one-carbon metabolism. Patients with a deficiency of this enzyme system have increased glycine in plasma, urine and cerebrospinal fluid (CSF) with an increased CSF: plasma glycine ratio. (PMID 16151895 ). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 2-Aminoacetate
- 2-Aminoacetic acid
- Aciport
- Amino-Acetate
- Amino-Acetic acid
- Aminoacetate
- Aminoacetic acid
- Aminoethanoate
- Aminoethanoic acid
- Glicoamin
- Glycocoll
- Glycolixir
- Glycosthene
- Gyn-Hydralin
- Padil
|
| Chemical Formula |
C2H5NO2 |
| Average Molecular Weight |
75.0666 |
| Monoisotopic Molecular Weight |
75.032028409 |
| IUPAC Name |
2-aminoacetic acid |
| Traditional IUPAC Name |
glycine |
| CAS Registry Number |
56-40-6 |
| SMILES |
NCC(O)=O |
| InChI Identifier |
InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5) |
| InChI Key |
DHMQDGOQFOQNFH-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Amino Acids, Peptides, and Analogues |
| Class |
Amino Acids and Derivatives |
| Sub Class |
Alpha Amino Acids and Derivatives |
| Other Descriptors |
- Aliphatic Acyclic Compounds
- Amino acids(KEGG)
- Common amino acids(KEGG)
- amino acid zwitterion(ChEBI)
|
| Substituents |
- Carboxylic Acid
- Primary Aliphatic Amine (Alkylamine)
|
| Direct Parent |
Alpha Amino Acids and Derivatives |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
|
| Application |
Not Available |
| Cellular locations |
- Extracellular
- Mitochondria
- Lysosome
- Peroxisome
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
262.2 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
249.0 mg/mL |
Not Available |
| LogP |
-3.21 |
HANSCH,C ET AL. (1995) |
|
| Predicted Properties |
|
| Spectra |
|
| Gas-MS Spectrum |
| 1H NMR Spectrum |
| 13C NMR Spectrum |
| MS/MS Spectrum Quattro_QQQ 10 |
| MS/MS Spectrum Quattro_QQQ 25 |
| MS/MS Spectrum Quattro_QQQ 40 |
| MS/MS Spectrum EI-B (HITACHI RMU-6M) |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 40 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 50 |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies ) |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) |
| [1H,1H] 2D NMR Spectrum |
| [1H,13C] 2D NMR Spectrum |
|
| Biological Properties |
| Cellular Locations |
- Extracellular
- Mitochondria
- Lysosome
- Peroxisome
|
| Biofluid Locations |
- Bile
- Blood
- Cerebrospinal Fluid (CSF)
- Saliva
- Urine
|
| Tissue Location |
- Bladder
- Fibroblasts
- Intestine
- Neuron
- Pancreas
- Placenta
- Kidney
- Epidermis
- Thyroid Gland
- Brain
- Myelin
- Prostate
- Platelet
- Spleen
- Stratum Corneum
|
| Pathways |
|
| Normal Concentrations |
|
| Bile |
Detected and Quantified |
|
>10 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
242.0 +/- 44.0 uM |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
258.0 +/- 64.0 uM |
Adult (>18 years old) |
Female |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
329.9 +/- 105.6 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
280.0 (140.0-420.0) uM |
Newborn (0-30 days old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
212.4 +/- 57.4 uM |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
230.0 (178.0-282.0) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
325.4 +/- 126.8 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
460.0 +/- 275.0 uM |
Newborn (0-30 days old) |
Not Specified |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
234.0 +/- 34.0 uM |
Children (1-13 year old) |
Male |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
4.7 +/- 1.5 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
9.0 (3.0-19.0) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
9.5 +/- 4.7 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
8.2 +/- 3.0 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
6.1 +/- 1.4 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
4.63 +/- 0.74 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
8.30 (5.88-10.7) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
11 +/- 4Â uM |
Not Specified |
Not Specified |
Normal |
Not Available |
| Saliva |
Detected and Quantified |
|
1-472 uM |
Adult (>18 years old) |
Male |
normal |
At rest without stimulation
|
| Saliva |
Detected and Quantified |
|
1-94 uM |
Adult (>18 years old) |
Male |
normal |
Salivary induction with a citric acid solution...
|
| Saliva |
Detected and Quantified |
|
>10 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
75.7 +/- 51.7 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
by GC-MS
|
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
165.0 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
151(48-233) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
119.95-599.74 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
151.0 (233-248) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
513.54 +/- 360.61 umol/mmol creatinine |
Infant (0-1 year old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
106 (44-300) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
urine by NMR
|
| Urine |
Detected and Quantified |
|
0.0027 - 0.0682 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
71.23 umol/mmol creatinine |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Both |
Normal |
Urine compound detected by GC-MS
|
| Urine |
Detected and Quantified |
|
128.1 +/- 65.5 umol/mmol creatinine |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
187.6 +/- 92.3 umol/mmol creatinine |
Adult (>18 years old) |
Female |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
15.0 (10.0-23.0) umol/mmol creatinine |
Newborn (0-30 days old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
30.0 +/- 19.0 umol/mmol creatinine |
Children (1-13 year old) |
Both |
Normal |
Not Available |
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Male |
Normal |
After green tea sonsumption
|
| Urine |
Detected and Quantified |
|
92.0 +/- 39.0 umol/mmol creatinine |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Male |
Normal |
After black tea sonsumption
|
| Urine |
Detected and Quantified |
|
139.0 +/- 86.0 umol/mmol creatinine |
Adult (>18 years old) |
Female |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
136.48 +/- 77.27 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
101 (37.0-250.6) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
by LC-MS/MS (Biocrates kit)
|
| Urine |
Detected and Quantified |
|
118.9 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
234.9 +/- 181.1 uM |
Adult (>18 years old) |
Not Specified |
Heart Transplant |
Not Available |
| Blood |
Detected and Quantified |
|
1090.0 (780.0-1400.0) uM |
Newborn (0-30 days old) |
Both |
Non-ketotic hyperglycinemia |
Not Available |
| Blood |
Detected and Quantified |
|
486.0 (232.0-740.0) uM |
Adult (>18 years old) |
Both |
D-Glyceric aciduria |
Not Available |
| Blood |
Detected and Quantified |
|
1000.0 (800.0-1200.0) uM |
Adult (>18 years old) |
Both |
D-Glyceric acidura |
Not Available |
| Blood |
Detected and Quantified |
|
210.0 (203.0-217.0) uM |
Adult (>18 years old) |
Both |
Refractory localization-related epilepsy (RLE) |
Not Available |
| Blood |
Detected and Quantified |
|
354.0 (309.0-399.0) uM |
Children (1-13 year old) |
Both |
Juvenile myoclonic epilepsy (JME) |
Not Available |
| Blood |
Detected and Quantified |
|
0.153 +/- 0.012 uM |
Elderly (>65 years old) |
Both |
Alzheimer's disease |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
9.7 +/- 4.9 uM |
Children (1-13 year old) |
Not Specified |
Leukemia |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
13.4 +/- 6.4 uM |
Children (1-13 year old) |
Not Specified |
Leukemia |
Acute Lymphoblastic Leukemia (ALL) with Central...
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
9.0405 (8.716-9.623) uM |
Not Specified |
Not Specified |
control |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
4.5 +/- 0.75 uM |
Adult (>18 years old) |
Both |
Schizophrenia |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.28 +/- 0.12 uM |
Adult (>18 years old) |
Both |
Alzheimer's disease |
Not Available |
| Urine |
Detected and Quantified |
|
3000.0 (1000.0-5000.0) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Carbamoyl phosphate synthetase deficiency |
Not Available |
| Urine |
Detected and Quantified |
|
0.0024 - 0.0339 umol/mmol creatinine |
Adult (>18 years old) |
Both |
ADPKD |
Not Available |
| Urine |
Detected and Quantified |
|
84.0 +/- 67.0 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Lung cancer |
Not Available |
| Urine |
Detected and Quantified |
|
0.010 +/- 0.001 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Alzheimer's disease |
Not Available |
| Urine |
Detected and Quantified |
|
178.2 +/- 6.4 umol/mmol creatinine |
Adult (>18 years old) |
Both |
3-Hydroxy-3- methylglutaryl-CoA lyase (HL) deficency |
Not Available |
| Urine |
Detected and Quantified |
|
135.8 +/- 5.8 umol/mmol creatinine |
Adult (>18 years old) |
Both |
3-Hydroxy-3- methylglutaryl-CoA lyase (HL) deficency |
Not Available |
| Urine |
Detected and Quantified |
|
53.1 +/- 1.8 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Arginosuccinic aciduria |
Not Available |
| Urine |
Detected and Quantified |
|
585.5 +/- 32.1 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Propionic acidemia |
Not Available |
| Urine |
Detected and Quantified |
|
550.00 (100.00-1000.00) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Iminoglycinuria |
Not Available |
| Urine |
Detected and Quantified |
|
2040.3 +/- 202.6 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Propionic acidemia |
Not Available |
| Urine |
Detected and Quantified |
|
49.9 +/- 1.3 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Tyrosinemia I |
Not Available |
| Urine |
Detected and Quantified |
|
176.2 +/- 9.2 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Tyrosinemia I |
Not Available |
| Urine |
Detected and Quantified |
|
82.2 +/- 4.1 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Phenylketonuria |
Not Available |
| Urine |
Detected and Quantified |
|
304.8 +/- 11.3 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Phenylketonuria |
Not Available |
| Urine |
Detected and Quantified |
|
233.7 +/- 10.5 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Maple syrup urine disease |
Not Available |
| Urine |
Detected and Quantified |
|
3205.1 +/- 83.4 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Aminoaciduria |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| D-Glyceric acidemia |
- Boneh A, Degani Y, Harari M: Prognostic clues and outcome of early treatment of nonketotic hyperglycinemia. Pediatr Neurol. 1996 Sep;15(2):137-41.
Pubmed: 8888048
- http://www.metagene.de/program/d.prg?mp=D-GLYCERIC%20ACIDURA
|
| Refractory localization-related epilepsy |
- Rainesalo S, Keranen T, Palmio J, Peltola J, Oja SS, Saransaari P: Plasma and cerebrospinal fluid amino acids in epileptic patients. Neurochem Res. 2004 Jan;29(1):319-24.
Pubmed: 14992292
|
| Juvenile myoclonic epilepsy |
- Rainesalo S, Keranen T, Palmio J, Peltola J, Oja SS, Saransaari P: Plasma and cerebrospinal fluid amino acids in epileptic patients. Neurochem Res. 2004 Jan;29(1):319-24.
Pubmed: 14992292
|
| Lung Cancer |
- Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, Mandal R, Sinelnikov I, Xia J, Jia L, Cruz JA, Lim E, Sobsey CA, Shrivastava S, Huang P, Liu P, Fang L, Peng J, Fradette R, Cheng D, Tzur D, Clements M, Lewis A, De Souza A, Zuniga A, Dawe M, Xiong Y, Clive D, Greiner R, Nazyrova A, Shaykhutdinov R, Li L, Vogel HJ, Forsythe I: HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2008 Oct 25.
Pubmed: 18953024
|
| Leukemia |
- Peng CT, Wu KH, Lan SJ, Tsai JJ, Tsai FJ, Tsai CH: Amino acid concentrations in cerebrospinal fluid in children with acute lymphoblastic leukemia undergoing chemotherapy. Eur J Cancer. 2005 May;41(8):1158-63. Epub 2005 Apr 14.
Pubmed: 15911239
|
| Alzheimer's disease |
- Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.
Pubmed: 17031479
|
| Schizophrenia |
- Do KQ, Lauer CJ, Schreiber W, Zollinger M, Gutteck-Amsler U, Cuenod M, Holsboer F: gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. J Neurochem. 1995 Dec;65(6):2652-62.
Pubmed: 7595563
|
| Carbamoyl Phosphate Synthetase Deficiency |
- http://www.metagene.de/program/d.prg?mp=CARBAMOYL%20PHOSPHATE%20SYNTHETASE%20DEFICIENCY%20(CPS)
|
| Iminoglycinuria |
- http://www.metagene.de/program/d.prg?mp=IMINOGLYCINURIA
|
|
| Associated OMIM IDs |
- 104300
(Alzheimer's disease)
- 237300
(Carbamoyl Phosphate Synthetase Deficiency)
- 605899
(D-Glyceric acidemia)
- 181500
(Schizophrenia)
- 606904
(Juvenile myoclonic epilepsy)
- 211980
(Lung Cancer)
- 242600
(Iminoglycinuria)
|
| External Links |
| DrugBank ID |
DB00145  |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
1062  |
| FoodDB ID |
FDB000484 |
| KNApSAcK ID |
C00001361  |
| Chemspider ID |
730  |
| KEGG Compound ID |
C00037  |
| BioCyc ID |
GLY  |
| BiGG ID |
33610  |
| Wikipedia Link |
Glycine  |
| NuGOwiki Link |
HMDB00123  |
| Metagene Link |
HMDB00123  |
| METLIN ID |
20  |
| PubChem Compound |
750  |
| PDB ID |
GLY  |
| ChEBI ID |
15428  |
| References |
| Synthesis Reference |
Anslow, Winston K.; King, Harold. Synthesis of glycine. Journal of the Chemical Society (1929), 2163-6. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Christie GR, Ford D, Howard A, Clark MA, Hirst BH: Glycine supply to human enterocytes mediated by high-affinity basolateral GLYT1. Gastroenterology. 2001 Feb;120(2):439-48.
Pubmed: 11159884
- Jones CM, Smith M, Henderson MJ: Reference data for cerebrospinal fluid and the utility of amino acid measurement for the diagnosis of inborn errors of metabolism. Ann Clin Biochem. 2006 Jan;43(Pt 1):63-6.
Pubmed: 16390611
- Peng CT, Wu KH, Lan SJ, Tsai JJ, Tsai FJ, Tsai CH: Amino acid concentrations in cerebrospinal fluid in children with acute lymphoblastic leukemia undergoing chemotherapy. Eur J Cancer. 2005 May;41(8):1158-63. Epub 2005 Apr 14.
Pubmed: 15911239
- Cynober LA: Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition. 2002 Sep;18(9):761-6.
Pubmed: 12297216
- Rainesalo S, Keranen T, Palmio J, Peltola J, Oja SS, Saransaari P: Plasma and cerebrospinal fluid amino acids in epileptic patients. Neurochem Res. 2004 Jan;29(1):319-24.
Pubmed: 14992292
- Bennett FI, Jackson AA: Glycine is not formed through the amino transferase reaction in human or rat placenta. Placenta. 1998 May;19(4):329-31.
Pubmed: 9639330
- Gomeza J, Ohno K, Hulsmann S, Armsen W, Eulenburg V, Richter DW, Laube B, Betz H: Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. Neuron. 2003 Nov 13;40(4):797-806.
Pubmed: 14622583
- Collins JW, Macdermott S, Bradbrook RA, Keeley FX Jr, Timoney AG: Is using ethanol-glycine irrigating fluid monitoring and 'good surgical practice' enough to prevent harmful absorption during transurethral resection of the prostate? BJU Int. 2006 Jun;97(6):1247-51.
Pubmed: 16686720
- Boneh A, Degani Y, Harari M: Prognostic clues and outcome of early treatment of nonketotic hyperglycinemia. Pediatr Neurol. 1996 Sep;15(2):137-41.
Pubmed: 8888048
- Dicke JM, Verges D, Kelley LK, Smith CH: Glycine uptake by microvillous and basal plasma membrane vesicles from term human placentae. Placenta. 1993 Jan-Feb;14(1):85-92.
Pubmed: 8456092
- Silwood CJ, Lynch E, Claxson AW, Grootveld MC: 1H and (13)C NMR spectroscopic analysis of human saliva. J Dent Res. 2002 Jun;81(6):422-7.
Pubmed: 12097436
- Shoemaker JD, Elliott WH: Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr. 1991 Jan 2;562(1-2):125-38.
Pubmed: 2026685
- Nicholson JK, O'Flynn MP, Sadler PJ, Macleod AF, Juul SM, Sonksen PH: Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects. Biochem J. 1984 Jan 15;217(2):365-75.
Pubmed: 6696735
- Prescot AP, de B Frederick B, Wang L, Brown J, Jensen JE, Kaufman MJ, Renshaw PF: In vivo detection of brain glycine with echo-time-averaged (1)H magnetic resonance spectroscopy at 4.0 T. Magn Reson Med. 2006 Mar;55(3):681-6.
Pubmed: 16453318
- Byard RW, Harrison R, Wells R, Gilbert JD: Glycine toxicity and unexpected intra-operative death. J Forensic Sci. 2001 Sep;46(5):1244-6.
Pubmed: 11569574
- Engelborghs S, Marescau B, De Deyn PP: Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease. Neurochem Res. 2003 Aug;28(8):1145-50.
Pubmed: 12834252
- Khan SA, Cox IJ, Hamilton G, Thomas HC, Taylor-Robinson SD: In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications. Liver Int. 2005 Apr;25(2):273-81.
Pubmed: 15780050
- Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.
Pubmed: 6321058
- Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel FA: Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects. J Neurochem. 1984 Mar;42(3):833-7.
Pubmed: 6198473
- Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4.
Pubmed: 19212411
|
| Enzymes |
|
|
|
|
|
|
|
|
| Name: |
D-amino-acid oxidase
|
| Reactions: |
- a D-amino acid + H2O + O2 = a 2-oxo acid + NH3 + H2O2 [RN:R01340]
|
| Gene Name: |
DAO |
| Uniprot ID: |
P14920  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
| Name: |
Aminopeptidase N
|
| Reactions: |
- Release of an N-terminal amino acid, Xaa!Yaa- from a peptide, amide or arylamide. Xaa is preferably Ala, but may be most amino acids including Pro (slow action). When a terminal hydrophobic residue is followed by a prolyl residue, the two may be released as an intact Xaa-Pro dipeptide ALL_REAC (other) R00899 R04951 COFACTOR Manganese [CPD:C00034]
- Zinc [CPD:C00038]
|
| Gene Name: |
ANPEP |
| Uniprot ID: |
P15144  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
| Name: |
Glycyl-tRNA synthetase
|
| Reactions: |
- ATP + glycine + tRNAGly = AMP + diphosphate + glycyl-tRNAGly [RN:R03654]
|
| Gene Name: |
GARS |
| Uniprot ID: |
P41250  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
| Name: |
Aminomethyltransferase, mitochondrial
|
| Reactions: |
- [protein]-S8-aminomethyldihydrolipoyllysine + tetrahydrofolate = [protein]-dihydrolipoyllysine + 5,10-methylenetetrahydrofolate + NH3 [RN:R04125]
|
| Gene Name: |
AMT |
| Uniprot ID: |
P48728  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
| Name: |
Glutathione synthetase
|
| Reactions: |
- ATP + gamma-L-glutamyl-L-cysteine + glycine = ADP + phosphate + glutathione [RN:R00497]
|
| Gene Name: |
GSS |
| Uniprot ID: |
P48637  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
| Name: |
Cytosol aminopeptidase
|
| Reactions: |
- Release of N-terminal proline from a peptide ALL_REAC (other) R00135 COFACTOR Manganese [CPD:C00034]
|
| Gene Name: |
LAP3 |
| Uniprot ID: |
P28838  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|